 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: December 2025
Volume 10 | Issue 12
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 10
Issue Published : 115
Article Submitted : 19455
Article Published : 8041
Total Authors : 21252
Total Reviewer : 769
Total Countries : 144
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati |
| Authors Name: | Om Raut , Rutushna Surwade , Ashish Wadekar , Sakshi Mankar |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_189915
|
| Published Paper Id: | IJRTI2405073 |
| Published In: | Volume 9 Issue 5, May-2024 |
| DOI: | |
| Abstract: | Hypertension is a significant global health concern, causing 10.8% of fatalities in India and 25% in Maharashtra. It accounts for 51% of stroke deaths and 45% of heart disease deaths. Early identification and treatment of hypertension and other risk factors have reduced cardiovascular disease deaths. Managing hypertension and reducing risk factors like diabetes, dyslipidemia, and smoking are crucial. Lowering blood pressure by 5 mmHg can reduce stroke risk by 34%. A study in Amravati, India, found that doctors prescribe antihypertensive medications like telmisartan for high blood pressure. Some drugs are cost-effective and economically beneficial, while others are less popular due to cost and physician preference. The study aimed to identify market share and address medication concerns. A study in Amravati, India, involving 100 pharmacists, 50 patients, and 10 physicians, found that doctors prescribe telmisartan for high blood pressure. Factors like efficacy, side effects, and comorbidities influenced patient decisions. High sales of certain drug categories, such as Telmikind-40, Concor-5, Beta-cap, Telista Trio CL 6.25, and Furosemide Inj. IP, can inform further pharma marketing and policy changes. |
| Keywords: | Heart Disease, Risk Factors, Telmisartan, Survey, Antihypertensive Medication, High Sales, Maharashtra India, Amravati District. |
| Cite Article: | "Survey on The Sales of Four-Molecule Antihypertensive Medications in The Private Healthcare Sector in Amravati", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.9, Issue 5, page no.485 - 497, May-2024, Available :http://www.ijrti.org/papers/IJRTI2405073.pdf |
| Downloads: | 000205129 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2405073
Registration ID:189915
Published In: Volume 9 Issue 5, May-2024
DOI (Digital Object Identifier):
Page No: 485 - 497 Country: Amravati, Maharashtra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2405073 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2405073 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2025 - All Rights Reserved - IJRTI | |||